Atlas Trials

Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

Clinical trial NCT02337062 · COMPLETED

Trial details

NCT number
NCT02337062
Sponsor
Acacia Pharma Ltd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
PONV
Start date
2015-02-01
Primary completion
2015-09-01
Enrollment
1147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.